153 related articles for article (PubMed ID: 23378575)
1. Chlamydia trachomatis clinical isolates identified as tetracycline resistant do not exhibit resistance in vitro: whole-genome sequencing reveals a mutation in porB but no evidence for tetracycline resistance genes.
O'Neill CE; Seth-Smith HMB; Van Der Pol B; Harris SR; Thomson NR; Cutcliffe LT; Clarke IN
Microbiology (Reading); 2013 Apr; 159(Pt 4):748-756. PubMed ID: 23378575
[TBL] [Abstract][Full Text] [Related]
2. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
Mpiga P; Ravaoarinoro M
Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
[TBL] [Abstract][Full Text] [Related]
3. Tetracycline resistance of Neisseria gonorrhoeae in Russia, 2015-2017.
Shaskolskiy B; Dementieva E; Leinsoo A; Petrova N; Chestkov A; Kubanov A; Deryabin D; Gryadunov D
Infect Genet Evol; 2018 Sep; 63():236-242. PubMed ID: 29883770
[TBL] [Abstract][Full Text] [Related]
4. In vitro tetracycline susceptibility of Chlamydia trachomatis in clinical specimens.
Hsu AH; Knelsen B; Kasatiya S
Antonie Van Leeuwenhoek; 1987; 53(3):191-6. PubMed ID: 3662489
[TBL] [Abstract][Full Text] [Related]
5. Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics.
Jones RB; Van der Pol B; Martin DH; Shepard MK
J Infect Dis; 1990 Dec; 162(6):1309-15. PubMed ID: 2230260
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal Recombination Targets in
Suchland RJ; Carrell SJ; Wang Y; Hybiske K; Kim DB; Dimond ZE; Hefty PS; Rockey DD
J Bacteriol; 2019 Dec; 201(23):. PubMed ID: 31501285
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.
Welsh LE; Gaydos CA; Quinn TC
Antimicrob Agents Chemother; 1992 Feb; 36(2):291-4. PubMed ID: 1318677
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of
Mestrovic T; Ljubin-Sternak S
Front Biosci (Landmark Ed); 2018 Jan; 23(4):656-670. PubMed ID: 28930567
[No Abstract] [Full Text] [Related]
9. Characterization and functional analysis of PorB, a Chlamydia porin and neutralizing target.
Kubo A; Stephens RS
Mol Microbiol; 2000 Nov; 38(4):772-80. PubMed ID: 11115112
[TBL] [Abstract][Full Text] [Related]
10. [Minimum inhibitory concentration and minimum bactericidal concentration of tetracycline and erythromycin in 35 recent Munich isolates of Chlamydia trachomatis].
Korting HC; Hartinger A
Hautarzt; 1988 Mar; 39(3):161-5. PubMed ID: 3378887
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines.
Samra Z; Rosenberg S; Soffer Y; Dan M
Diagn Microbiol Infect Dis; 2001 Mar; 39(3):177-9. PubMed ID: 11337185
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of tetracycline & ciprofloxacin against Chlamydia trachomatis isolates from conjunctivitis patients.
Madhavan HN; Roy S; Malathy J
Indian J Med Res; 1996 Mar; 103():138-41. PubMed ID: 9062038
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro susceptibility of a tetracycline-resistant Chlamydia trachomatis strain isolated in Toulouse (France).
Lefèvre JC; Lépargneur JP
Sex Transm Dis; 1998 Aug; 25(7):350-2. PubMed ID: 9713914
[TBL] [Abstract][Full Text] [Related]
14. Growth and development of tetracycline-resistant Chlamydia suis.
Lenart J; Andersen AA; Rockey DD
Antimicrob Agents Chemother; 2001 Aug; 45(8):2198-203. PubMed ID: 11451674
[TBL] [Abstract][Full Text] [Related]
15. Tetracycline-resistant Chlamydia trachomatis in Toulouse, France.
Lefevre JC; Lepargneur JP; Guion D; Bei S
Pathol Biol (Paris); 1997 May; 45(5):376-8. PubMed ID: 9296087
[TBL] [Abstract][Full Text] [Related]
16. Frequency of spontaneous mutations that confer antibiotic resistance in Chlamydia spp.
Binet R; Maurelli AT
Antimicrob Agents Chemother; 2005 Jul; 49(7):2865-73. PubMed ID: 15980362
[TBL] [Abstract][Full Text] [Related]
17. In vitro assays of the efficacy of antimicrobial agents in controlling Chlamydia trachomatis propagation.
Lee CK; Bowie WR; Alexander ER
Antimicrob Agents Chemother; 1978 Mar; 13(3):441-5. PubMed ID: 162541
[TBL] [Abstract][Full Text] [Related]
18. Incidence of antibiotic resistance in Campylobacter jejuni isolated in Alberta, Canada, from 1999 to 2002, with special reference to tet(O)-mediated tetracycline resistance.
Gibreel A; Tracz DM; Nonaka L; Ngo TM; Connell SR; Taylor DE
Antimicrob Agents Chemother; 2004 Sep; 48(9):3442-50. PubMed ID: 15328109
[TBL] [Abstract][Full Text] [Related]
19. Paeniclostridium sordellii and Clostridioides difficile encode similar and clinically relevant tetracycline resistance loci in diverse genomic locations.
Vidor CJ; Bulach D; Awad M; Lyras D
BMC Microbiol; 2019 Mar; 19(1):53. PubMed ID: 30832583
[TBL] [Abstract][Full Text] [Related]
20. Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan.
Takahashi S; Hamasuna R; Yasuda M; Ishikawa K; Hayami H; Uehara S; Yamamoto S; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sato J; Hanaki H; Masumori N; Kiyota H; Egawa S; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Wada K; Kobayashi K; Matsubara A; Matsumoto T; Eto M; Tatsugami K; Kuroiwa K; Ito K; Hosobe T; Hirayama H; Narita H; Yamaguchi T; Ito S; Sumii T; Kawai S; Kanokogi M; Kawano H; Chokyu H; Uno S; Monden K; Kaji S; Kawahara M; Takayama K; Ito M; Yoshioka M; Kano M; Konishi T; Kadena H; Nishi S; Nishimura H; Yamauchi T; Maeda S; Horie M; Ihara H; Matsumura M; Shirane T; Takeyama K; Akiyama K; Takahashi K; Ikuyama T; Inatomi H; Yoh M
J Infect Chemother; 2016 Sep; 22(9):581-6. PubMed ID: 27452428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
